subject: CHEBI:71219

object_name: Malignant Paraganglioma


subject: CHEBI:71219

subject_name: Pazopanib

object_name: paragangliomas 1

tested_intervention: yes


subject: CHEBI:71219

object_name: Recurrent Adrenal Gland Pheochromocytoma


subject: CHEBI:71219

object_name: malignant adrenal gland pheochromocytoma


subject: CHEBI:77260

subject_name: Omeprazole

object_name: Reflux


subject: CHEBI:77260

object_name: Throat clearing


subject: CHEBI:77260

object_name: voice disorders


subject: CHEBI:77260

object_name: Dysphonia


subject: CHEBI:77260

object_name: Hoarse voice


subject: CHEBI:77260

object_name: Cough


subject: CHEBI:77260

object_name: Cough, CTCAE


subject: CHEBI:28072

object_name: nasopharyngeal carcinoma

tested_intervention: unsure


subject: CHEBI:28072

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:70744

subject_name: Gly-Pro


subject: CHEBI:70744


subject: UniProtKB:P08668

subject_name: GP_HANTV Envelopment polyprotein (sprot)


subject: UniProtKB:P08668


subject: UniProtKB:P27312

subject_name: GP_PUUMS Envelopment polyprotein (sprot)


subject: UniProtKB:P27312


subject: UNII:H8MTN7XVC2

subject_name: Mitometh


subject: UNII:H8MTN7XVC2


subject: PR:000029794

subject_name: mitochondrial import inner membrane translocase subunit Tim8 A


subject: PR:000029794


subject: CHEBI:137064

subject_name: Galunisertib


subject: CHEBI:137064


subject: UMLS:C3883362

subject_name: Programmed Death Receptor-1 Blocking Antibody


subject: UMLS:C3883362


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: CHEBI:50859

subject_name: Bexarotene

object_name: Cutaneous T-cell lymphoma refractory


subject: UNII:F40IRN5981

subject_name: Chiauranib

object_name: small cell lung carcinoma


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: brain neoplasm


subject: UMLS:C3540708

object_name: Grade III Childhood Astrocytoma


subject: UMLS:C3540708

object_name: Adult Anaplastic Astrocytoma


subject: UMLS:C3540708

object_name: anaplastic astrocytoma


subject: UMLS:C3540708

object_name: glioblastoma


subject: UMLS:C3540708

object_name: Brain Stem Glioblastoma


subject: UMLS:C3540708

object_name: glioma susceptibility 1


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: UMLS:C3540705


subject: PUBCHEM.COMPOUND:73352623

subject_name: Pbmc

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:73352623

object_name: melanoma


subject: UMLS:C0722196

subject_name: Nutropin AQ

object_name: Loss of Chromosome 18q


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: carcinoma of esophagus


subject: CHEBI:4026

object_name: esophageal cancer


subject: CHEBI:4026

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:4026

object_name: neoplasm of esophagus


subject: CHEBI:4026

object_name: stage IV esophageal cancer


subject: CHEBI:4026

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:4026

object_name: Unresectable Esophageal Carcinoma


subject: CHEBI:4026

object_name: rectal carcinoma


subject: CHEBI:4026

object_name: rectal cancer


subject: CHEBI:4026

object_name: myeloproliferative syndrome


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:3368

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:3368

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:3368

object_name: gastric cancer


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985

object_name: hematopoietic and lymphoid cell neoplasm


subject: GTOPDB:4985

object_name: hematopoietic and lymphoid system neoplasm


subject: GTOPDB:4985

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985


subject: GTOPDB:4985

object_name: B-cell chronic lymphocytic leukemia


subject: GTOPDB:4985

object_name: acute lymphoblastic leukemia


subject: GTOPDB:4985

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: GTOPDB:4985

object_name: Myelodysplasia


subject: GTOPDB:4985

object_name: plasma cell myeloma


subject: GTOPDB:4985

object_name: acute myeloid leukemia by FAB classification


subject: GTOPDB:4985

object_name: acute myeloid leukemia


subject: GTOPDB:4985

object_name: non-Hodgkin lymphoma


subject: GTOPDB:4985

object_name: Hodgkin Disease


subject: GTOPDB:4985

object_name: Adult Hodgkin Lymphoma


subject: GTOPDB:4985

object_name: Childhood Hodgkin Lymphoma


subject: PR:000001379

object_name: carcinoma of esophagus


subject: PR:000001379

object_name: esophageal cancer


subject: PR:000001379

object_name: Childhood Esophageal Carcinoma


subject: PR:000001379

object_name: neoplasm of esophagus


subject: PR:000001379

object_name: hematopoietic and lymphoid cell neoplasm


subject: PR:000001379

object_name: hematopoietic and lymphoid system neoplasm


subject: PR:000001379

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: PR:000001379

object_name: stage IV esophageal cancer


subject: PR:000001379

object_name: Stomach cancer


subject: PR:000001379

object_name: gastric cancer


subject: PR:000001379

object_name: Malignant neoplasm of stomach stage IV


subject: PR:000001379

object_name: Unresectable Esophageal Carcinoma


subject: PR:000001379

object_name: rectal carcinoma


subject: PR:000001379

object_name: rectal cancer


subject: PR:000001379

object_name: myeloproliferative syndrome


subject: PR:000001379

object_name: acute lymphoblastic leukemia


subject: PR:000001379

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PR:000001379

object_name: Myelodysplasia


subject: PR:000001379

object_name: non-Hodgkin lymphoma


subject: PR:000001379

object_name: Hodgkin Disease


subject: PR:000001379

object_name: Adult Hodgkin Lymphoma


subject: PR:000001379

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C5139755

subject_name: Human interleukin-2

object_name: carcinoma of esophagus


subject: UMLS:C5139755

object_name: esophageal cancer


subject: UMLS:C5139755

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5139755

object_name: neoplasm of esophagus


subject: UMLS:C5139755

object_name: hematopoietic and lymphoid cell neoplasm


subject: UMLS:C5139755

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C5139755

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UMLS:C5139755

object_name: stage IV esophageal cancer


subject: UMLS:C5139755

object_name: Stomach cancer


subject: UMLS:C5139755

object_name: gastric cancer


subject: UMLS:C5139755

object_name: Malignant neoplasm of stomach stage IV


subject: UMLS:C5139755

object_name: Unresectable Esophageal Carcinoma


subject: UMLS:C5139755

object_name: rectal carcinoma


subject: UMLS:C5139755

object_name: rectal cancer


subject: UMLS:C5139755

object_name: myeloproliferative syndrome


subject: UMLS:C5139755

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5139755

object_name: acute lymphoblastic leukemia


subject: UMLS:C5139755

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C5139755

object_name: Myelodysplasia


subject: UMLS:C5139755

object_name: plasma cell myeloma


subject: UMLS:C5139755

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5139755

object_name: acute myeloid leukemia


subject: UMLS:C5139755

object_name: non-Hodgkin lymphoma


subject: UMLS:C5139755

object_name: Hodgkin Disease


subject: UMLS:C5139755

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C5139755

object_name: Childhood Hodgkin Lymphoma


subject: UNII:6T4O391P5Y

subject_name: Vactosertib

object_name: colorectal cancer


subject: UNII:6T4O391P5Y

object_name: colorectal carcinoma


subject: UNII:6T4O391P5Y

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:6T4O391P5Y

object_name: carcinoma of esophagus


subject: UNII:6T4O391P5Y

object_name: esophageal cancer


subject: UNII:6T4O391P5Y

object_name: Childhood Esophageal Carcinoma


subject: UNII:6T4O391P5Y

object_name: neoplasm of esophagus


subject: UNII:6T4O391P5Y

object_name: hematopoietic and lymphoid cell neoplasm


subject: UNII:6T4O391P5Y

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:6T4O391P5Y

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: UNII:6T4O391P5Y

object_name: stage IV esophageal cancer


subject: UNII:6T4O391P5Y

object_name: Stomach cancer


subject: UNII:6T4O391P5Y

object_name: gastric cancer


subject: UNII:6T4O391P5Y

object_name: Malignant neoplasm of stomach stage IV


subject: UNII:6T4O391P5Y

object_name: Unresectable Esophageal Carcinoma


subject: UNII:6T4O391P5Y

object_name: rectal carcinoma


subject: UNII:6T4O391P5Y

object_name: rectal cancer


subject: UNII:6T4O391P5Y

object_name: myeloproliferative syndrome


subject: UNII:6T4O391P5Y

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:6T4O391P5Y

object_name: acute lymphoblastic leukemia


subject: UNII:6T4O391P5Y

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:6T4O391P5Y

object_name: Myelodysplasia


subject: UNII:6T4O391P5Y

object_name: plasma cell myeloma


subject: UNII:6T4O391P5Y

object_name: acute myeloid leukemia by FAB classification


subject: UNII:6T4O391P5Y

object_name: acute myeloid leukemia


subject: UNII:6T4O391P5Y

object_name: non-Hodgkin lymphoma


subject: UNII:6T4O391P5Y

object_name: Hodgkin Disease


subject: UNII:6T4O391P5Y

object_name: Adult Hodgkin Lymphoma


subject: UNII:6T4O391P5Y

object_name: Childhood Hodgkin Lymphoma


subject: CHEBI:9434

subject_name: Telmisartan

object_name: brain small vessel disease 3


subject: CHEBI:9434

object_name: vascular dementia


subject: CHEBI:9434

object_name: stroke disorder


subject: CHEBI:9434

object_name: cerebrovascular disorder


subject: CHEBI:9434

object_name: Stroke (heart beat)


subject: CHEBI:9434

object_name: Stroke, CTCAE


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: Alzheimer disease type 1


subject: UMLS:C3714501

object_name: Alzheimer disease


subject: UMLS:C3714501

object_name: mild neurocognitive disorder


subject: UMLS:C3714501

object_name: mild cognitive impairment


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: CHEBI:5931


subject: UMLS:C2830125

object_name: brain cancer


subject: UMLS:C2830125

object_name: soft tissue neoplasm


subject: CHEBI:145371

subject_name: Binimetinib


subject: CHEBI:145371


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: loiasis


subject: CHEBI:73604

object_name: ocular onchocerciasis


subject: CHEBI:15365

subject_name: Aspirin

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:119915

subject_name: Fentanyl

object_name: acute myocardial infarction


subject: CHEBI:119915


subject: CHEBI:58097


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:68558

subject_name: Ticagrelor


subject: CHEBI:68558


subject: PUBCHEM.COMPOUND:54677977

subject_name: Teriflunomide

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:72564

subject_name: Temozolomide

object_name: Disorder due to radiotherapy


subject: CHEBI:74224

object_name: Sepsis


subject: CHEBI:74224

object_name: Sepsis, CTCAE


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:27514


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:28088


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: endometrial cancer


subject: CHEBI:63605

object_name: uterine corpus cancer


subject: CHEBI:63605

object_name: endometrial carcinoma


subject: UNII:IN59K53GI9

subject_name: Vilaprisan

object_name: leiomyoma


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: adult lymphoma


subject: UMLS:C3852764

object_name: lymphoma


subject: UMLS:C3852764

object_name: pediatric lymphoma


subject: CHEBI:135239

subject_name: Indobufen

object_name: coronary artery disorder


subject: CHEBI:135239

object_name: coronary atherosclerosis


subject: UNII:G2UX40NTG9

subject_name: TYROSINASE

object_name: metastatic melanoma


subject: UMLS:C1510427

subject_name: Recombinant MAGE-3.1 Antigen


subject: PR:000022994

subject_name: thermosensitive gluconokinase


subject: UNII:JJX4JHS4PO

object_name: malignant epithelioid mesothelioma


subject: UNII:JJX4JHS4PO

object_name: non-small cell lung carcinoma


subject: UNII:JJX4JHS4PO

object_name: pancreatic adenocarcinoma


subject: UMLS:C2346687


subject: UMLS:C2346687


subject: UMLS:C2346687


subject: CHEBI:34565

subject_name: benzo[b]fluoranthene

object_name: asthma


subject: UniProtKB:P04186

subject_name: CFAB_MOUSE Complement factor B (sprot)


subject: PR:000005374

subject_name: complement factor B


subject: CHEBI:50733

subject_name: nutraceutical

object_name: Weight loss


subject: CHEBI:50733

object_name: Weight Loss, CTCAE


subject: CHEBI:32278

subject_name: Urapidil

object_name: hypertension


subject: CHEBI:32278

object_name: Hypertension, CTCAE


subject: CHEBI:32278

object_name: preeclampsia


subject: CHEBI:23965

subject_name: estradiol

object_name: Muscle Atrophy


subject: UMLS:C5555590

subject_name: ATR Inhibitor ART0380

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5555590

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5555590

object_name: Embolism, Tumor


subject: UMLS:C5555590

object_name: Neoplasm Metastasis


subject: UMLS:C5555590

object_name: Recurrent Endometrial Cancer


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:7936

subject_name: Paroxetine

object_name: premature ejaculation


subject: UMLS:C5420249

subject_name: Extended Release Metformin Hydrochloride

object_name: endometrial carcinoma


subject: UMLS:C5420249

object_name: Endometrial Intraepithelial Neoplasia


subject: UNII:6867Q6IKOD

subject_name: FLORBETAPIR

object_name: Alzheimer disease type 1


subject: CHEBI:39867

subject_name: Valproic acid

object_name: metastatic colorectal cancer


subject: CHEBI:74705

subject_name: Met-Leu

object_name: esophageal adenocarcinoma


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UMLS:C1948073


subject: UNII:2Q1GS25JWN

subject_name: AVOTERMIN

object_name: keloid


subject: UMLS:C3179443

subject_name: avotermin


subject: MESH:C000722752

subject_name: mRNA-1273.214 COVID-19 vaccine


subject: CHEBI:49668

subject_name: Gefitinib

object_name: cancer


subject: CHEBI:49668

object_name: neoplasm


subject: UMLS:C3714638

subject_name: Pyridoxine Drug Class

object_name: Suppressed lactation


subject: CHEBI:27306

subject_name: vitamin B6


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: differentiated thyroid carcinoma


subject: CHEBI:75998

subject_name: Trametinib


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: Mesothelioma


subject: PUBCHEM.COMPOUND:135402009

object_name: mesothelial neoplasm


subject: PUBCHEM.COMPOUND:135402009

object_name: malignant mesothelioma


subject: PUBCHEM.COMPOUND:135402009

object_name: thymoma


subject: PUBCHEM.COMPOUND:135402009

object_name: thymus neoplasm


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: UMLS:C2830194

object_name: human papilloma virus infection


subject: UMLS:C4331002

subject_name: Personalized Peptide Cancer Vaccine NEO-PV-01

object_name: melanoma


subject: UMLS:C4331002

object_name: transitional cell carcinoma


subject: UMLS:C4331002

object_name: lung cancer


subject: UMLS:C4331002

object_name: lung neoplasm


subject: UMLS:C4331002

object_name: lung carcinoma


subject: UMLS:C4331002

object_name: non-small cell lung carcinoma


subject: UMLS:C4331002

object_name: urinary bladder carcinoma


subject: UMLS:C4331002

object_name: urinary bladder cancer


subject: UMLS:C4331002

object_name: bladder tumor


subject: UMLS:C4331002

object_name: skin neoplasm


subject: UMLS:C4331002

object_name: skin cancer


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Pemphigoid


subject: UMLS:C3658854


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: heart disorder


subject: PUBCHEM.COMPOUND:9831414

object_name: HIV infection


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: CHEBI:3724

subject_name: citalopram hydrobromide

object_name: Childhood Breast Carcinoma


subject: CHEBI:3724

object_name: breast carcinoma


subject: CHEBI:3724

object_name: breast cancer


subject: CHEBI:3724

object_name: Hot Flashes, CTCAE


subject: CHEBI:3724

object_name: Hot flashes


subject: CHEBI:3724

object_name: psychosocial effects of cancer and its treatment


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:36791


subject: CHEBI:36791


subject: CHEBI:36791


subject: CHEBI:36791


subject: CHEBI:36791


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: autoimmune thrombocytopenia


subject: CHEBI:61057

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:61057

object_name: autoimmune thrombocytopenic purpura


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: GTOPDB:8998

subject_name: quilizumab

object_name: urticaria


subject: GTOPDB:8998

object_name: reported urticaria (physical finding)


subject: GTOPDB:8998

object_name: Urticaria, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL2109456

subject_name: QUILIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109456


subject: CHEMBL.COMPOUND:CHEMBL2109456


subject: UMLS:C4726648

subject_name: Quilizumab


subject: UMLS:C4726648


subject: UMLS:C4726648


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Still Disease


subject: PR:000023317


subject: CHEBI:16822

subject_name: choline sulfate

object_name: Pregnant


subject: CHEBI:15354

subject_name: Choline


subject: UMLS:C3898831

subject_name: Hyperpolarized Carbon C 13 Pyruvate

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: tuberculosis


subject: CHEBI:60648

object_name: acute coronary syndrome


subject: CHEBI:60648

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:53498

subject_name: triacetylcellulose

object_name: lupus nephritis


subject: UMLS:C2962221

subject_name: TAC


subject: CHEBI:165821

subject_name: CpA

object_name: non-small cell lung carcinoma


subject: CHEBI:35498

subject_name: diuretic

object_name: Primary amyloidosis of light chain type


subject: CHEBI:35498

object_name: AL amyloidosis


subject: UMLS:C0012798

subject_name: Diuretics


subject: UMLS:C0012798


subject: UMLS:C1550678

subject_name: Water Specimen

object_name: diabetes mellitus


subject: UMLS:C1550678

object_name: hyperglycemia


subject: CHEBI:15377

subject_name: Water


subject: CHEBI:15377


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: acute myeloid leukemia, t(3;5)(q25;q34)


subject: CHEBI:28680

subject_name: Cytarabine


subject: PUBCHEM.COMPOUND:3685

object_name: Treatment related acute myeloid leukaemia


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:93776

subject_name: Pevonedistat


subject: CHEBI:93776


subject: CHEBI:93776


subject: CHEBI:135883

subject_name: Canfosfamide

object_name: ovarian cancer


subject: CHEBI:135883

object_name: ovarian neoplasm


subject: UMLS:C1258106

subject_name: TLK 286


subject: UMLS:C1258106


subject: CHEBI:17394

subject_name: Theanine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: CHEBI:17394


subject: UMLS:C0076380

subject_name: theanine


subject: UMLS:C0076380


subject: CHEBI:229233

subject_name: Ritlecitinib

object_name: Crohn disease


subject: UNII:3X8387Q25N


subject: CHEBI:18248

subject_name: Iron

object_name: Increased reactive oxygen species production


subject: CHEBI:18248

object_name: Iron Overload


subject: CHEBI:18248

object_name: iron poisoning


subject: CHEBI:18248

object_name: Iron Overload, CTCAE


subject: CHEBI:29034

subject_name: Ferric cation


subject: CHEBI:29034


subject: CHEBI:29034


subject: CHEBI:29034


subject: UMLS:C1166521

subject_name: Ferrum metallicum, Homeopathic preparation


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C1166521


subject: UMLS:C3714701

subject_name: Iron Drug Class


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: UMLS:C3714701


subject: CHEBI:74224

object_name: prostate carcinoma


subject: CHEBI:74224

object_name: prostate cancer


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:27514


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:28088


subject: UMLS:C5666968

subject_name: KRAS G12C Inhibitor MK-1084

object_name: rectum adenocarcinoma


subject: UMLS:C5666968

object_name: colon adenocarcinoma


subject: UMLS:C1145196

subject_name: INJECTION, FONDAPARINUX SODIUM, 0.5 MG ADMINISTERED

object_name: thrombophilia due to thrombin defect


subject: CHEBI:85990

subject_name: Panobinostat

object_name: HIV infection


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: pancreatic neoplasm


subject: CHEBI:68841

object_name: exocrine pancreatic carcinoma


subject: CHEBI:68841

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:22671105

subject_name: Edotecarin

object_name: gastric neoplasm


subject: CHEBI:173077

subject_name: Copanlisib

object_name: neoplasm


subject: CHEBI:28918

subject_name: Epinephrine

object_name: inflammatory bowel disease


subject: CHEBI:28918

object_name: Crohn disease


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Ligament injury


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: CHEBI:41423

subject_name: Celecoxib


subject: CHEBI:59527


subject: CHEBI:91939

subject_name: (R)-Naproxen


subject: CHEBI:7476

subject_name: Naproxen


subject: DRUGBANK:DB16516


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: Infection


subject: CHEBI:63611

object_name: infectious disease


subject: CHEBI:63611

object_name: Adverse Event Associated with Infection


subject: UMLS:C3898587

subject_name: Liposomal Mitoxantrone Hydrochloride

object_name: non-Hodgkin lymphoma


subject: UNII:768FW21J3L

subject_name: Famitinib

object_name: Stage IV Nasopharyngeal Carcinoma


subject: UNII:768FW21J3L

object_name: Nasopharyngeal cancer recurrent


subject: GTOPDB:13924

subject_name: mazdutide

object_name: Androgen excess


subject: CHEMBL.COMPOUND:CHEMBL5095358

subject_name: MAZDUTIDE


subject: UMLS:C5565538


subject: CHEMBL.COMPOUND:CHEMBL3545192

subject_name: MIRVETUXIMAB

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: malignant epithelial tumor of ovary


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: fallopian tube carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: fallopian tube cancer


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: primary peritoneal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: papillary serous cystadenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL3545192

object_name: peritoneal carcinoma


subject: UMLS:C5238119

subject_name: Mirvetuximab


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5238119


subject: UMLS:C5418018

subject_name: SIRPa-Fc-CD40L Fusion Protein SL-172154


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: UMLS:C5418018


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: Oropharyngeal candidiasis


subject: CHEBI:46081

subject_name: Fluconazole


subject: UMLS:C3712106

object_name: acute myocardial infarction


subject: UMLS:C3712106

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Electroencephalogram


subject: UMLS:C1527137

object_name: Sedation


subject: UMLS:C1527137

object_name: Sedated


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:16796


subject: CHEBI:16796


subject: CHEBI:94531

subject_name: belinostat

object_name: non-small cell lung carcinoma


subject: MESH:D013607

subject_name: Tablets

object_name: bacterial infectious disease


subject: CHEBI:38037

subject_name: methanesulfonate salt


subject: UMLS:C3853872

subject_name: electrolyte solution

object_name: kidney failure


subject: UMLS:C5442122

subject_name: VITAMIN B

object_name: cardiovascular disorder


subject: UMLS:C1704763

subject_name: B Vitamin Family


subject: CHEBI:75769

subject_name: B vitamin


subject: CHEMBL.COMPOUND:CHEMBL2108015

subject_name: VITAMIN B COMPLEX


subject: CHEBI:60056

object_name: cocaine dependence


subject: CHEBI:60056

object_name: opiate dependence


subject: CHEBI:27958

subject_name: Cocaine


subject: CHEBI:27958


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: methylphenidate poisoning of undetermined intent


subject: PUBCHEM.COMPOUND:126480208

subject_name: Ganfort

object_name: OPTN-related open angle glaucoma


subject: PUBCHEM.COMPOUND:126480208

object_name: open-angle glaucoma


subject: PUBCHEM.COMPOUND:126480208

object_name: ocular hypertension


subject: PUBCHEM.COMPOUND:126480208

object_name: Ocular hypertension


subject: CHEBI:85164

subject_name: Nintedanib


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Malignant neoplasm of female breast


subject: UNII:6A901E312A

subject_name: Panitumumab

object_name: malignant glioma


subject: UNII:6A901E312A

object_name: brain cancer


subject: UMLS:C4054250


subject: UMLS:C4054250


subject: MESH:C068639

subject_name: pantogar

object_name: Chronic telogen effluvium


subject: CHEBI:35940

subject_name: Protirelin

object_name: thyroid tumor


subject: CHEBI:35940

object_name: thyroid gland carcinoma


subject: CHEBI:35940

object_name: thyroid cancer


subject: PUBCHEM.COMPOUND:124389175


subject: PUBCHEM.COMPOUND:124389175


subject: PUBCHEM.COMPOUND:124389175


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: pneumonia


subject: CHEBI:41879

object_name: COVID-19-Associated Pneumonia


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: adult hepatocellular carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: pediatric hepatocellular carcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174

object_name: liver cancer


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: UMLS:C5706541

subject_name: Sirolimus Topical Gel PTX-022

object_name: pachyonychia congenita


subject: CHEBI:57858

subject_name: atropinium

object_name: myopia


subject: CHEBI:91541


subject: UMLS:C1161352

subject_name: Atropinum, atropine


subject: CHEBI:9150

subject_name: Simvastatin

object_name: vitiligo-associated multiple autoimmune disease susceptibility 1


subject: CHEBI:9150

object_name: vitiligo


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Rhizarthrosis


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEBI:192712

subject_name: Paxlovid


subject: UMLS:C5564905

subject_name: nirmatrelvir and ritonavir drug combination


subject: UMLS:C5564078

subject_name: CILGAVIMAB/TIXAGEVIMAB


subject: CHEBI:15367

subject_name: Tretinoin

object_name: Oligometastatic malignant neoplasm


subject: CHEBI:15367

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2134724

subject_name: IPRATROPIUM BROMIDE

object_name: childhood onset asthma


subject: CHEBI:5957

subject_name: ipratropium bromide hydrate


subject: PUBCHEM.COMPOUND:3021749


subject: UNII:J697UZ2A9J


subject: PUBCHEM.COMPOUND:657309

subject_name: Ipratropium


subject: UNII:D07V79Q44T

object_name: Solid Neoplasm


subject: UMLS:C1566164


subject: CHEBI:3387

subject_name: Carbamazepine

object_name: Parkinson disease


subject: CHEBI:499361

subject_name: Aprepitant

object_name: plasma cell myeloma


subject: CHEBI:31348

subject_name: Capecitabine

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:31348

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:31348

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:31348

object_name: Pancreatic carcinoma recurrent


subject: CHEBI:31348

object_name: Ovarian cancer stage IV


subject: CHEBI:31348

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: stage IV pancreatic cancer


subject: CHEBI:31348

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:31348

object_name: recurrent gastric cancer


subject: CHEBI:31348

object_name: Breast cancer recurrent


subject: CHEBI:31348

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:31348

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:31348

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:31348

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:31348

object_name: Rectal cancer stage IV


subject: CHEBI:31348

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:31348

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:31348

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:31348

object_name: stage IA breast cancer


subject: CHEBI:31348

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:31348

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:31348

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:31348

object_name: Malignant neoplasm of colon stage IV


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Pancreatic carcinoma recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Ovarian cancer stage IV


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: stage IV pancreatic cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:43805

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IB Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Breast cancer stage II


subject: PUBCHEM.COMPOUND:43805

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IA Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: stage IA breast cancer


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED

object_name: Pancreatic carcinoma recurrent


subject: UMLS:C1314429

object_name: Ovarian cancer stage IV


subject: UMLS:C1314429

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: stage IV pancreatic cancer


subject: UMLS:C1314429

object_name: Breast cancer recurrent


subject: UMLS:C1314429

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C1314429

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C1314429

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C1314429

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C1314429

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IB Breast Cancer AJCC v7


subject: UMLS:C1314429

object_name: Breast cancer stage II


subject: UMLS:C1314429

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UMLS:C1314429

object_name: Stage IA Breast Cancer AJCC v7


subject: UMLS:C1314429

object_name: stage IA breast cancer


subject: CHEBI:62880

subject_name: Veliparib

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:62880

object_name: gastric adenocarcinoma


subject: CHEBI:62880

object_name: Recurrent Ovarian Germ Cell Tumor


subject: CHEBI:62880

object_name: Ovarian germ cell cancer stage IV


subject: CHEBI:62880

object_name: Stage IV Ovarian Germ Cell Tumor AJCC v6 and v7


subject: CHEBI:62880

object_name: pancreatic adenocarcinoma


subject: CHEBI:62880

object_name: Ovarian cancer stage IV


subject: CHEBI:62880

object_name: stage IV pancreatic cancer


subject: CHEBI:62880

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:62880

object_name: recurrent gastric cancer


subject: CHEBI:62880

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:62880

object_name: Recurrent Rectal Cancer


subject: CHEBI:62880

object_name: Colon cancer recurrent


subject: CHEBI:62880

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:62880

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:62880

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:62880

object_name: Stage IV Rectal Cancer AJCC v8


subject: CHEBI:62880

object_name: Stage IV Rectal Cancer AJCC v7


subject: CHEBI:62880

object_name: Rectal cancer stage IV


subject: CHEBI:62880

object_name: Stage IV Rectal Cancer AJCC v6


subject: CHEBI:62880

object_name: Carcinoma breast stage IV


subject: CHEBI:62880

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Stage IB Breast Cancer AJCC v7


subject: CHEBI:62880

object_name: Breast cancer stage II


subject: CHEBI:62880

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:62880

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:62880

object_name: Stage IA Breast Cancer AJCC v7


subject: CHEBI:62880

object_name: stage IA breast cancer


subject: CHEBI:62880

object_name: Stage IV Colon Cancer AJCC v8


subject: CHEBI:62880

object_name: Stage IV Colon Cancer AJCC v6


subject: CHEBI:62880

object_name: Stage IV Colon Cancer AJCC v7


subject: CHEBI:62880

object_name: Malignant neoplasm of colon stage IV


subject: PUBCHEM.COMPOUND:78092786

subject_name: Etelcalcetide

object_name: end stage renal failure


subject: PUBCHEM.COMPOUND:78092786

object_name: Chronic uremia


subject: UMLS:C3712398


subject: UMLS:C3712398


subject: PUBCHEM.COMPOUND:18218213

subject_name: QW

object_name: type 2 diabetes mellitus


subject: CHEBI:141431

subject_name: Gln-Trp


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: Childhood Breast Carcinoma


subject: CHEBI:63605

object_name: breast carcinoma


subject: CHEBI:63605

object_name: breast cancer


subject: CHEBI:63605

object_name: breast neoplasm


subject: CHEBI:80343

subject_name: Mecasermin


subject: CHEBI:80343

object_name: Insulin resistance


subject: CHEBI:80343

object_name: hyperglycemia


subject: CHEBI:80343

object_name: Hyperglycemia, CTCAE


subject: CHEBI:80343

object_name: Glucose in blood specimen above reference range


subject: CHEBI:192614

subject_name: Homosildenafil

object_name: Cirrhosis


subject: CHEBI:192614

object_name: liver cirrhosis


subject: UNII:L6WO34R9YG

subject_name: N-Desmethyl sildenafil (UK-103,320)


subject: UNII:L6WO34R9YG


subject: PUBCHEM.COMPOUND:131769997

subject_name: Hydromorphone 3-beta-O-glucuronide


subject: PUBCHEM.COMPOUND:131769997


subject: CHEBI:183660

subject_name: Acetildenafil


subject: CHEBI:183660


subject: UNII:80X7B1F6NW

subject_name: LODENAFIL


subject: UNII:80X7B1F6NW


subject: CHEBI:9139

subject_name: Sildenafil


subject: CHEBI:9139


subject: UMLS:C1614968

subject_name: Sativex

object_name: cannabis abuse


subject: PUBCHEM.COMPOUND:3222

object_name: Heart failure with normal ejection fraction


subject: CHEBI:4784

subject_name: Enalapril


subject: UNII:3H8GSZ4SQL

subject_name: Avatrombopag


subject: UNII:3H8GSZ4SQL

object_name: Thrombocytopenia caused by drugs


subject: UNII:3H8GSZ4SQL

object_name: Procedural haemorrhage


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: squamous cell carcinoma


subject: UMLS:C3896806


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C4722367


subject: DRUGBANK:DB17528


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UMLS:C4758796


subject: UNII:FIJ3OLQ3N8


subject: UMLS:C2826130

subject_name: Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207


subject: UMLS:C4722124


subject: UNII:B0L24T8TB7


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: UMLS:C3658787


subject: UNII:2BT4C47RUI

subject_name: Necitumumab


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:15365

subject_name: Aspirin

object_name: Increased drug resistance


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UMLS:C0753357

subject_name: MultiHance

object_name: CNS disorder


subject: UMLS:C0753357

object_name: central nervous system cancer


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: acute kidney failure


subject: CHEBI:16347

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:16347

object_name: kidney failure


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Post-Dural Puncture Headaches


subject: CHEBI:7514

subject_name: Neostigmine


subject: UMLS:C0770246

subject_name: PROTEIN SUPPLEMENTS

object_name: Atrophy, Disuse


subject: CHEBI:168442

subject_name: Urolithin A


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: central centrifugal cicatricial alopecia


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: polycystic liver disease 1


subject: CHEBI:168396

object_name: autosomal dominant polycystic liver disease


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: UNII:5GCF8EPY6R

subject_name: Idursulfase beta

object_name: Hunter Syndrome


subject: KEGG.COMPOUND:C00816

subject_name: Collagenase

object_name: ulcer disease


subject: UNII:9X7O8V25IT

subject_name: collagenase


subject: MESH:C005519

subject_name: iruxol


subject: CHEBI:6706

subject_name: Mecamylamine

object_name: Depressed mood


subject: UMLS:C0721082

subject_name: Inversine


subject: UNII:D07V79Q44T

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1566164


subject: CHEBI:85990

subject_name: Panobinostat


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Breath holding with temper


subject: CHEBI:39867

subject_name: Valproic acid


subject: UMLS:C5418770

subject_name: Oligo-fucoidan

object_name: Advanced Hepatocellular Carcinoma


subject: CHEBI:47458

subject_name: Saracatinib

object_name: pancreatic neoplasm


subject: CHEBI:47458

object_name: exocrine pancreatic carcinoma


subject: CHEBI:47458

object_name: malignant pancreatic neoplasm


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: UMLS:C1706679


subject: CHEMBL.COMPOUND:CHEMBL2108628

subject_name: PACLITAXEL POLIGLUMEX

object_name: lung cancer


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: lung neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108628

object_name: lung carcinoma


subject: CHEBI:139072

object_name: hematopoietic and lymphoid cell neoplasm


subject: CHEBI:139072

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:139072

object_name: Malignant Solid Neoplasm


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:8614


subject: UMLS:C0178601

subject_name: Dopamine Agonists

object_name: prolactinoma


subject: UMLS:C3536925

subject_name: Dopaminergic Agonist [EPC]


subject: CHEBI:17858

subject_name: oxiglutatione

object_name: non-small cell lung carcinoma


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:16856

subject_name: Glutathione


subject: CHEBI:181098

subject_name: Sinomenine

object_name: osteoarthritis, knee


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline

object_name: heart failure


subject: PUBCHEM.COMPOUND:54671203

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:54671203

object_name: ST-elevation myocardial infarction


subject: PUBCHEM.COMPOUND:54671203

object_name: ST Elevation Myocardial Infarction


subject: PUBCHEM.COMPOUND:54671203

object_name: anterolateral myocardial infarction


subject: PUBCHEM.COMPOUND:54671203

object_name: Anterior Myocardial Infarction by ECG Finding


subject: UNII:JG8OB4UL9Y

subject_name: FILGOTINIB MALEATE

object_name: rheumatoid arthritis


subject: UMLS:C5419370

subject_name: Filgotinib maleate


subject: UMLS:C4744992

subject_name: Factor B Inhibitor LNP023

object_name: IgA Nephropathy


subject: CHEBI:28887

subject_name: Ofatumumab

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C1541395


subject: CHEBI:157802

subject_name: Cys-Arg

object_name: cardiovascular disorder


subject: CHEBI:28073

subject_name: Chromium


subject: CHEBI:49544

subject_name: Chromic cation


subject: PR:000004968

subject_name: calretinin


subject: PR:000006466

subject_name: dehydrogenase/reductase SDR family member 4


subject: PR:000025662

subject_name: complement decay-accelerating factor


subject: UniProtKB:Q8VHX2

subject_name: EDAD_MOUSE Ectodysplasin-A receptor-associated adapter protein (sprot)


subject: PR:000006889

subject_name: ectodysplasin-A receptor-associated adapter protein


subject: UMLS:C4287690

subject_name: BET Bromodomain Inhibitor ZEN-3694

object_name: endometrial carcinoma


subject: UMLS:C4287690

object_name: endometrial endometrioid adenocarcinoma


subject: UMLS:C4287690

object_name: endometrium adenocarcinoma


subject: UMLS:C4287690

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C4287690

object_name: endometrial clear cell adenocarcinoma


subject: UMLS:C4287690

object_name: Endometrial Low Grade Endometrioid Adenocarcinoma


subject: UMLS:C4287690

object_name: Ovarian Low Grade Endometrioid Adenocarcinoma


subject: UMLS:C4287690

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UMLS:C4287690

object_name: ovarian clear cell adenocarcinoma


subject: UMLS:C4287690

object_name: high grade ovarian serous adenocarcinoma


subject: PUBCHEM.COMPOUND:90199447

subject_name: TUVUSERTIB


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: PUBCHEM.COMPOUND:90199447


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Non-Hodgkin Lymphoma by Clinical Course


subject: CHEBI:7772

subject_name: omeprazole

object_name: eosinophilic esophagitis


subject: CHEBI:7772

object_name: Eosinophilic infiltration of the esophagus


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:77260


subject: UNII:OX5LRQ5H6K

subject_name: FIANLIMAB

object_name: skin squamous cell carcinoma


subject: UNII:OX5LRQ5H6K

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C4329332

subject_name: Fianlimab


subject: UMLS:C4329332


subject: CHEBI:231005

subject_name: 2-(Trifluoromethyl)isonicotinic acid

object_name: invasive breast carcinoma


subject: CHEBI:231005

object_name: breast adenocarcinoma


subject: CHEBI:231005

object_name: HER2/Neu Negative


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:233197

subject_name: devimistat

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C2703200

subject_name: CPI 613


subject: UNII:0W79NDQ608

subject_name: Milvexian

object_name: acute coronary syndrome


subject: CHEBI:7726

subject_name: octreotide


subject: CHEBI:7726

object_name: Octreotide adverse reaction


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: endometrium neoplasm


subject: UMLS:C3641122


subject: CHEBI:83766

subject_name: Olaparib


subject: UMLS:C3641122

object_name: tumor suppressor gene on chromosome 11


subject: CHEBI:44897

object_name: osteoarthritis, knee


subject: CHEBI:18021

subject_name: phosphoenolpyruvate


subject: CHEBI:135909

subject_name: peplomycin


subject: UNII:P14877CDX2

subject_name: Polyestradiol phosphate


subject: CHEBI:189965

subject_name: Prosapogenin

object_name: hypertension


subject: CHEBI:189965

object_name: Hypertension, CTCAE


subject: CHEBI:189965

object_name: type 2 diabetes mellitus


subject: CHEBI:189965

object_name: maturity-onset diabetes of the young type 1


subject: DRUGBANK:DB01404

subject_name: Ginseng


subject: DRUGBANK:DB01404


subject: DRUGBANK:DB01404


subject: DRUGBANK:DB01404


subject: CHEBI:8871

subject_name: Risperidone

object_name: Manic Disorder


subject: CHEBI:64312

subject_name: Memantine

object_name: migraine


subject: CHEBI:17230

subject_name: homocysteine

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UMLS:C0019878


subject: UNII:G1G66XE93W

object_name: non-small cell lung carcinoma


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Cognitive impairment


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: hypopharyngeal carcinoma


subject: GTOPDB:7988

object_name: hypopharynx cancer


subject: GTOPDB:7988

object_name: oropharyngeal carcinoma


subject: GTOPDB:7988

object_name: oropharynx cancer


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C0666155

subject_name: ABT 089

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: autosomal dominant cerebellar ataxia


subject: UMLS:C3274911

subject_name: Gliolan

object_name: Anal intraepithelial neoplasia


subject: UMLS:C3274911

object_name: in situ carcinoma


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:71219

subject_name: Pazopanib

object_name: salivary gland carcinoma


subject: CHEBI:95165

object_name: Refractory Leukemia


subject: CHEBI:50131

subject_name: Decitabine


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin


subject: UNII:467LU0UCUW

subject_name: Sarizotan

object_name: Neuroleptic-Induced Tardive Dyskinesia


subject: CHEBI:27732

subject_name: Caffeine


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: UMLS:C2987686

subject_name: Sodium Bicarbonate Solution

object_name: Acute kidney injury caused by contrast agent


subject: PUBCHEM.COMPOUND:138319683

object_name: plasma cell myeloma


subject: CHEBI:114785

subject_name: Erlotinib

object_name: skin neoplasm


subject: CHEBI:114785

object_name: skin cancer


subject: UMLS:C5556649

subject_name: Anti-KLK2/CD3 Bispecific Antibody JNJ-78278343

object_name: Advanced prostate cancer


subject: UMLS:C5907973

subject_name: Anti-PSMA/Anti-CD28 Bispecific Antibody JNJ-87189401


subject: PUBCHEM.COMPOUND:152165

object_name: Low back pain


subject: PUBCHEM.COMPOUND:152165

object_name: Back Pain without Radiation


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:132922


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:6129

object_name: Abnormal uterine bleeding


subject: CHEBI:6129

object_name: pain agnosia


subject: CHEBI:6129

object_name: Pain insensitivity


subject: CHEBI:8614

subject_name: Psilocybin

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:6375

subject_name: Lansoprazole

object_name: Laryngopharyngeal Reflux


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Ewing sarcoma of bone


subject: CHEBI:68646

object_name: pediatric osteosarcoma


subject: CHEBI:68646

object_name: Osteosarcoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: acute lymphoblastic leukemia


subject: UNII:3A189DH42V

object_name: Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:70839

subject_name: Dasatinib


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:94265

subject_name: Cerubidin


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate


subject: PUBCHEM.COMPOUND:16760419


subject: CHEBI:4911

subject_name: Etoposide


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Helicobacter pylori infectious disease


subject: UMLS:C4547390

subject_name: Vigil vaccine

object_name: Advanced Melanoma


subject: UMLS:C1145201

subject_name: INJECTION, PARICALCITOL, 1 MCG

object_name: diabetic kidney disease


subject: UMLS:C1145201

object_name: cardiovascular disorder


subject: CHEBI:7931

subject_name: Paricalcitol


subject: CHEBI:7931


subject: CHEBI:167309

subject_name: Methadone

object_name: heroin dependence


subject: CHEBI:139554

subject_name: magnetic nanoparticle

object_name: Wasting


subject: CHEBI:139554

object_name: Cachexia


subject: CHEBI:139554

object_name: Acute malnutrition in childhood


subject: CHEBI:49956

subject_name: Xenon

object_name: cystic fibrosis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Hoarse voice


subject: CHEBI:41879

object_name: Hoarseness, CTCAE


subject: CHEBI:41879

object_name: pharyngitis


subject: CHEBI:41879

object_name: Pharyngalgia


subject: CHEBI:41879

object_name: Sore Throat, CTCAE


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Platinum-Sensitive Lung Small Cell Carcinoma


subject: UMLS:C3641122


subject: CHEBI:125354

subject_name: Plerixafor

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:6456

subject_name: Lidocaine

object_name: carpal tunnel syndrome 1


subject: CHEBI:6456

object_name: carpal tunnel syndrome


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:44423

subject_name: Hydroxyurea

object_name: Neck Carcinoma


subject: CHEBI:44423

object_name: head and neck neoplasm


subject: CHEBI:44423

object_name: head and neck cancer


subject: CHEBI:60802

subject_name: ropivacaine

object_name: pain agnosia


subject: CHEBI:60802

object_name: Pain insensitivity


subject: UMLS:C5417951

subject_name: Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a

object_name: Plexosarcoma


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: actinic keratosis


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:16977

subject_name: Alanine


subject: UNII:RXJ96XL94H

subject_name: Elenbecestat

object_name: Alzheimer disease


subject: UMLS:C0751598

subject_name: Alferon

object_name: leukemia


subject: UMLS:C0751598

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:76470875

subject_name: Glecaprevir

object_name: HIV infection


subject: PUBCHEM.COMPOUND:76668718

subject_name: Pibrentasvir


subject: UMLS:C5555534

object_name: chronic obstructive pulmonary disease


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Closed Fracture


subject: CHEBI:474053

object_name: Wounds and Injuries


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Excessive gingival display


subject: PUBCHEM.COMPOUND:641528

subject_name: Avidin

object_name: Deep Venous Thrombosis Related to COVID-19


subject: PUBCHEM.COMPOUND:641528

object_name: Deep venous thrombosis


subject: CHEMBL.COMPOUND:CHEMBL4297569

subject_name: AVIDIN


subject: CHEMBL.COMPOUND:CHEMBL4297569


subject: UNII:K2T918I23K

subject_name: Idrabiotaparinux Sodium


subject: UNII:K2T918I23K


subject: UMLS:C5418410


subject: UMLS:C5418410


subject: CHEBI:68590

subject_name: fidaxomicin

object_name: inflammatory bowel disease


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: UMLS:C1650872

subject_name: POC (substance)


subject: UMLS:C1650872

object_name: clostridium difficile infection


subject: UMLS:C4721962

object_name: Parkinson disease


subject: CHEBI:5847

subject_name: Raltitrexed

object_name: bile duct adenoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: CHEBI:4026

object_name: aplastic anemia


subject: CHEBI:4026

object_name: idiopathic aplastic anemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:133021

subject_name: Venetoclax

object_name: Intermediate Risk Acute Myeloid Leukemia


subject: CHEBI:133021

object_name: High Risk Acute Myeloid Leukemia


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: PUBCHEM.COMPOUND:1805


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:48502

subject_name: tert-butoxycarbonyl group

object_name: hepatitis C


subject: CHEBI:48502

object_name: HIV infection


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: UNII:D99YVK4L0X

object_name: desmoplastic small round cell tumor


subject: UNII:D99YVK4L0X

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Mild non-proliferative diabetic retinopathy


subject: UNII:ZL1R02VT79

object_name: diabetic cataract


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: neoplasm


subject: CHEBI:16347

subject_name: Levocarnitine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:16347

object_name: obesity


subject: CHEBI:16347

object_name: Obesity, CTCAE


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: childhood neoplasm


subject: UNII:52CMI0WC3Y

object_name: cancer or benign tumor


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C0306371

subject_name: Humulin R

object_name: diabetes mellitus


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C0719563

subject_name: Cream Base

object_name: skin sensitivity to sun


subject: UMLS:C0719563

object_name: photoparoxysmal response 1


subject: UMLS:C0719563

object_name: Photosensitivity, CTCAE


subject: CHEBI:125427

object_name: vitamin D deficiency


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:76127

subject_name: Cimicoxib

object_name: major depressive disorder


subject: UNII:5PKM8P0G5I

subject_name: Vonicog alfa

object_name: acquired von willebrand syndrome


subject: UMLS:C0962969

subject_name: RAD 001

object_name: glioblastoma


subject: UMLS:C0962969

object_name: Childhood Glioblastoma


subject: UMLS:C0962969

object_name: adult glioblastoma


subject: UMLS:C0962969

object_name: Adult Gliosarcoma


subject: UMLS:C0962969

object_name: gliosarcoma


subject: UMLS:C0962969

object_name: Childhood Gliosarcoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: UMLS:C5447427

subject_name: Anti-CFH Monoclonal Antibody GT103

object_name: non-small cell lung carcinoma


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: Unspecified Staphylococcus infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:63598

subject_name: Levofloxacin


subject: UNII:DEW6X41BEK

subject_name: Tildrakizumab

object_name: Chronic small plaque psoriasis


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: nephrotic syndrome


subject: CHEBI:85078

object_name: Nephrotic Syndrome, CTCAE


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: UMLS:C0521942


subject: UMLS:C3896893

object_name: Inclusion Body Myopathy, Sporadic


subject: UMLS:C3896893

object_name: inclusion body myositis


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Diastolic dysfunction


subject: CHEBI:9144

subject_name: Silibinin

object_name: leukemia


subject: CHEBI:9144

object_name: childhood leukemia


subject: CHEBI:9144

object_name: Drug toxicity


subject: CHEBI:125451

subject_name: silymarin


subject: CHEBI:125451


subject: CHEBI:125451


subject: UMLS:C3854029

subject_name: antiseptics ethanol

object_name: Recurrent oral herpes


subject: UMLS:C3854030

subject_name: CNS depressants ethanol


subject: CHEBI:16236

subject_name: Ethanol


subject: UNII:G6UF363ECX

object_name: castration-resistant prostate carcinoma


subject: UNII:G6UF363ECX

object_name: Stage IVB Prostate Cancer AJCC v8


subject: UMLS:C4308025

subject_name: AAA 617


subject: UMLS:C4308025


subject: UMLS:C4287739

subject_name: ERK Inhibitor LTT462


subject: UMLS:C4287739

object_name: melanoma


subject: UNII:15JL80DG6H

subject_name: Naporafenib


subject: UNII:15JL80DG6H


subject: UMLS:C4086981

subject_name: Pan-raf inhibitor lxh254


subject: UMLS:C4086981


subject: CHEBI:230905

subject_name: Ribociclib


subject: CHEBI:95089

subject_name: Ipatasertib

object_name: cancer


subject: GTOPDB:13850

subject_name: ifinatamab deruxtecan

object_name: Advanced Malignant Solid Neoplasm


subject: GTOPDB:13850

object_name: Childhood Malignant Solid Neoplasm


subject: GTOPDB:13850

object_name: Malignant Solid Neoplasm


subject: UNII:C6I0GC0GX5

subject_name: IFINATAMAB DERUXTECAN


subject: UNII:C6I0GC0GX5


subject: UNII:C6I0GC0GX5


subject: UMLS:C5417871


subject: UMLS:C5417871


subject: UMLS:C5417871


subject: UNII:4T36H88UA7

subject_name: Apalutamide


subject: CHEBI:75984

subject_name: Flecainide

object_name: atrial fibrillation


subject: CHEBI:75984

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:75984

object_name: Atrial Fibrillation, CTCAE


subject: UNII:8KFO2187CP

subject_name: Ciforadenant

object_name: nonpapillary renal cell carcinoma


subject: UNII:8KFO2187CP

object_name: clear cell renal carcinoma


subject: UNII:8KFO2187CP

object_name: renal cell adenocarcinoma


subject: UNII:8KFO2187CP

object_name: renal cell carcinoma


subject: UMLS:C4724815

subject_name: ciforadenant


subject: UMLS:C4724815


subject: UMLS:C4724815


subject: UMLS:C4724815


subject: UMLS:C3554917

subject_name: Abilify Maintena

object_name: sexual disorder


subject: UMLS:C3554917

object_name: physiological sexual disorder


subject: CHEBI:31236

subject_name: Aripiprazole


subject: CHEBI:31236


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: ovarian cancer


subject: UNII:8M7YSN2KII

object_name: ovarian neoplasm


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: MESH:D003470

subject_name: Culture Media


subject: MESH:D003470


subject: UMLS:C1705217

subject_name: Medium (Substance)


subject: UMLS:C1705217


subject: GTOPDB:10236

subject_name: volociximab

object_name: age-related macular degeneration


subject: CHEMBL.COMPOUND:CHEMBL2108061

subject_name: VOLOCIXIMAB


subject: UMLS:C1541160


subject: CHEBI:80961

object_name: anus cancer


subject: CHEBI:80961

object_name: anal carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:25357

subject_name: mitomycin


subject: CHEBI:25357


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: UMLS:C5554973

subject_name: ERK1/2 Inhibitor UCT-01-097

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: non-small cell lung carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: hepatitis C


subject: UNII:5M691HL4BO

subject_name: glatiramer acetate

object_name: Crohn disease


subject: CHEBI:8499

subject_name: Propranolol

object_name: Migrainous vertigo


subject: CHEBI:9943

subject_name: Venlafaxine


subject: UMLS:C4722737

subject_name: AXS 05

object_name: treatment resistant depression


subject: UMLS:C4722737


subject: UMLS:C4722737

object_name: Depressed mood


subject: UMLS:C4722737

object_name: Cancer patients and suicide and depression


subject: UMLS:C4722737

object_name: Depressed - symptom


subject: UMLS:C4722737

object_name: Depression, CTCAE


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146178


subject: CHEBI:146178


subject: CHEBI:146178


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:4470


subject: CHEBI:3219

subject_name: Bupropion


subject: CHEBI:3219


subject: UNII:SE6KE496VO

object_name: Irritable bowel syndrome with diarrhea


subject: PR:000004692

subject_name: Bcl-2-related protein A1

object_name: triple-negative breast carcinoma


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:51707

subject_name: diboron


subject: UMLS:C0009499

subject_name: Complement C1


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: CHEBI:30083

subject_name: dicarbon


subject: CHEBI:29294

subject_name: dideuterium


subject: PR:000011357

subject_name: NPC intracellular cholesterol transporter 2


subject: UniProtKB:P03114

subject_name: VE1_HPV16 Replication protein E1 (sprot)


subject: PR:000015454

subject_name: sperm-associated antigen 11B


subject: PR:000022039

subject_name: dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex


subject: PR:000015453

subject_name: sperm-associated antigen 11A


subject: UNII:FOF5155FMZ

object_name: urothelial carcinoma


subject: UNII:FOF5155FMZ

object_name: transitional cell carcinoma


subject: UNII:FOF5155FMZ

object_name: Advanced cancer


subject: UNII:FOF5155FMZ

object_name: bladder tumor


subject: UNII:FOF5155FMZ

object_name: urinary bladder carcinoma


subject: UNII:FOF5155FMZ

object_name: urinary bladder cancer


subject: UNII:FOF5155FMZ

object_name: childhood bladder carcinoma


subject: UNII:FOF5155FMZ

object_name: Childhood Solid Neoplasm


subject: UNII:FOF5155FMZ

object_name: Adult Solid Neoplasm


subject: UNII:FOF5155FMZ

object_name: Solid Neoplasm


subject: UMLS:C5446299

subject_name: Eganelisib


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C5446299


subject: UMLS:C0021761


subject: UMLS:C1328727


subject: UMLS:C4722192

subject_name: Interleukin-7 human recombinant


subject: CHEBI:52172

subject_name: Nilotinib

object_name: Mucosal lentiginous melanoma


subject: CHEBI:52172

object_name: acral lentiginous melanoma


subject: CHEBI:92769

subject_name: Iobenguane

object_name: adrenal gland pheochromocytoma


subject: CHEBI:92769

object_name: pheochromocytoma


subject: CHEBI:92769

object_name: Childhood Neuroblastoma


subject: CHEBI:92769

object_name: neuroblastoma


subject: UMLS:C0733516

subject_name: Avitene

object_name: Postoperative Complications


subject: UMLS:C0733516

object_name: Body Substance Discharge


subject: CHEBI:187893

subject_name: Baclofen

object_name: Ruminations


subject: CHEBI:135949

subject_name: Ambrisentan

object_name: aneurysm


subject: CHEBI:145421

subject_name: rigosertib sodium

object_name: Pancreatic adenocarcinoma metastatic


subject: UMLS:C2347619


subject: CHEBI:197268

subject_name: Tocotrienol

object_name: atrial fibrillation


subject: CHEBI:197268

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:197268

object_name: Atrial Fibrillation, CTCAE


subject: UNII:KP2MW85SSQ

subject_name: TOCOTRIENOLS


subject: UNII:KP2MW85SSQ


subject: UNII:KP2MW85SSQ


subject: CHEBI:29954

subject_name: L-tryptophan residue

object_name: Depressed mood


subject: CHEBI:29954

object_name: Cancer patients and suicide and depression


subject: CHEBI:29954

object_name: Depressed - symptom


subject: CHEBI:29954

object_name: Depression, CTCAE


subject: CHEBI:46858

subject_name: L-tyrosine residue


subject: CHEBI:46858


subject: CHEBI:46858


subject: CHEBI:46858


subject: CHEBI:17895

subject_name: Tyrosine


subject: CHEBI:17895


subject: CHEBI:17895


subject: CHEBI:17895


subject: CHEBI:27897

subject_name: tryptophan


subject: CHEBI:27897


subject: CHEBI:27897


subject: CHEBI:27897


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Cholangiocarcinoma resectable


subject: PUBCHEM.COMPOUND:2767

object_name: Stage II Intrahepatic Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IB Intrahepatic Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage III Intrahepatic Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8


subject: PUBCHEM.COMPOUND:2767

object_name: Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:WZ0PYQ6VLU

subject_name: TIGULIXOSTAT

object_name: Primary gout


subject: UNII:WZ0PYQ6VLU

object_name: Gout flare


subject: UNII:WZ0PYQ6VLU

object_name: Urate tophus


subject: DRUGBANK:DB18799

subject_name: Tigulixostat


subject: DRUGBANK:DB18799


subject: DRUGBANK:DB18799


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: end stage renal failure


subject: UNII:C137DTR5RG

object_name: Chronic uremia


subject: UNII:C137DTR5RG

object_name: Disorder of olfactory system


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:28177


subject: CHEBI:6121

subject_name: Ketamine

object_name: Anhedonia


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931

object_name: bipolar II disorder


subject: CHEBI:6931

object_name: bipolar I disorder


subject: CHEBI:6931

object_name: mood disorder


subject: CHEBI:6931

object_name: bipolar disorder


subject: CHEBI:6931


subject: UMLS:C0963149

subject_name: Definity

object_name: heart disorder


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:17688

subject_name: Nicotine

object_name: Passive Smoke Exposure


subject: CHEBI:6121

object_name: QT INTERVAL, VARIATION IN


subject: UNII:38073MQB2A

subject_name: Umbralisib

object_name: mantle cell lymphoma


subject: UMLS:C0939311

subject_name: Detrol LA

object_name: Urinary Urgency


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:6504

object_name: concussion


subject: CHEBI:6504

object_name: Mild Traumatic Brain Injury


subject: CHEBI:38940

subject_name: Sunitinib

object_name: peritoneum cancer


subject: CHEBI:38940

object_name: fallopian tube carcinoma


subject: CHEBI:38940

object_name: fallopian tube cancer


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: portal vein thrombosis


subject: CHEBI:70746

object_name: Portal Vein Thrombosis, CTCAE


subject: CHEBI:70746

object_name: liver cirrhosis


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: CHEBI:70752


subject: CHEBI:78425

subject_name: Albiglutide

object_name: heart failure


subject: CHEBI:78425

object_name: congestive heart failure


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Atrophy of orbital structure


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0242903

subject_name: Anesthetics, Inhalation

object_name: coronary artery disorder


subject: UMLS:C0242903

object_name: coronary atherosclerosis


subject: UMLS:C0242904

subject_name: Anesthetics, Intravenous


subject: UMLS:C0242904


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:145374

subject_name: Enasidenib

object_name: adult acute myeloid leukemia


subject: CHEBI:145374

object_name: childhood acute myeloid leukemia


subject: PUBCHEM.COMPOUND:78140854

subject_name: Ivosidenib


subject: PUBCHEM.COMPOUND:78140854


subject: CHEBI:30879

subject_name: alcohol

object_name: cannabis abuse


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:94531

subject_name: belinostat

object_name: Myelodysplasia


subject: CHEBI:94531

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:94531

object_name: childhood myelodysplastic syndrome


subject: CHEBI:94531

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:94531

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:94531

object_name: acute myeloid leukemia


subject: CHEBI:94531

object_name: acute lymphoblastic leukemia


subject: CHEBI:94531

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: High grade serous carcinoma


subject: CHEBI:28748

object_name: ovarian epithelial tumor


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:17596

subject_name: Inosine

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:17596

object_name: amyotrophic lateral sclerosis


subject: CHEBI:34385

subject_name: Dalfampridine

object_name: optic neuritis


subject: CHEBI:135951

subject_name: Pyronaridine

object_name: malaria


subject: CHEBI:135951

object_name: Malaria recrudescence


subject: CHEBI:135951

object_name: protozoa infectious disease


subject: CHEBI:135951

object_name: parasitic infectious disease


subject: CHEBI:135951

object_name: parasitemia


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: inherited lipid metabolism disorder


subject: GTOPDB:12990

subject_name: sintilimab

object_name: Locally Advanced Head and Neck Squamous Cell Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: CHEBI:73510

subject_name: Glu-Thr

object_name: infertility


subject: PR:000010374

subject_name: UNC93-like protein MFSD11


subject: CHEMBL.COMPOUND:CHEMBL5095039

subject_name: GALLIUM GA 68 GOZETOTIDE

object_name: Stage IIC Prostate Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL5095039

object_name: Stage IVB Prostate Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL5095039

object_name: Stage III Prostate Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL5095039

object_name: prostate adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095039

object_name: Biochemically Recurrent Prostate Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095039

object_name: castration-resistant prostate carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095039

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: UNII:9AG41L3AOQ


subject: CHEBI:6931

subject_name: Midazolam

object_name: kidney failure


subject: CHEBI:6931

object_name: Renal Failure, CTCAE


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Anterior Cruciate Ligament Tear


subject: CHEBI:4910

subject_name: Etomidate

object_name: Hemodynamic instability


subject: CHEBI:4910

object_name: Other and unspecified adrenocortical insufficiency


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Alzheimer disease type 1


subject: CHEBI:9943

subject_name: Venlafaxine


subject: CHEBI:9943

object_name: Alzheimer disease


subject: PUBCHEM.COMPOUND:9824461

subject_name: remimazolam

object_name: Poisoning by, adverse effect of and underdosing of other general anesthetics


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: acute myocardial infarction


subject: PUBCHEM.COMPOUND:92043599

object_name: Acute Myocardial Infarction by ECG Finding


subject: UMLS:C0376541

subject_name: Recombinant Erythropoietin


subject: UMLS:C0376541


subject: DRUGBANK:DB17952

object_name: toxic or nutritional optic neuropathy


subject: DRUGBANK:DB17952

object_name: optic nerve disorder


subject: DRUGBANK:DB17952

object_name: relapsing-remitting multiple sclerosis


subject: DRUGBANK:DB17952

object_name: demyelination; in optic neuritis


subject: CHEBI:136049

subject_name: Mirodenafil

object_name: impotence


subject: UMLS:C1871941


subject: UMLS:C5854428

subject_name: Anti-EGFR/anti-CD3 Tumor Protease-activated T-cell Engager JANX008

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5854428

object_name: clear cell renal carcinoma


subject: UMLS:C5854428

object_name: renal cell adenocarcinoma


subject: UMLS:C5854428

object_name: renal cell carcinoma


subject: UMLS:C5854428

object_name: colorectal carcinoma


subject: UMLS:C5854428

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5854428

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5854428

object_name: triple-negative breast carcinoma


subject: UMLS:C5854428

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5854428

object_name: non-small cell lung carcinoma


subject: UMLS:C5854428

object_name: small cell lung carcinoma


subject: CHEBI:59594

subject_name: Colesevelam

object_name: type 1 diabetes mellitus 1


subject: CHEBI:59594

object_name: type 1 diabetes mellitus


subject: CHEBI:6402

subject_name: Leflunomide

object_name: temporal arteritis


subject: CHEBI:6402

object_name: polymyalgia rheumatica


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: Coronavinae infectious disease


subject: UMLS:C3180100

object_name: post-traumatic stress disorder


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: penicillin allergy


subject: CHEBI:51254

object_name: Allergy to penicillin


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: glucose metabolism disease


subject: CHEBI:16796

subject_name: Melatonin


subject: DRUGBANK:DB05173


subject: DRUGBANK:DB05173


subject: DRUGBANK:DB05173

object_name: pneumonia


subject: DRUGBANK:DB05173

object_name: COVID-19-Associated Pneumonia


subject: MESH:D000077325

subject_name: Ringer's Lactate

object_name: Hyperlactatemia


subject: CHEBI:15372

object_name: hypertension


subject: CHEBI:15372

object_name: Hypertension, CTCAE


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: PUBCHEM.COMPOUND:129630809


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: GTOPDB:13663

subject_name: ponsegromab

object_name: Cachexia


subject: GTOPDB:13663

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UNII:GXA6PF0254

subject_name: PONSEGROMAB


subject: UNII:GXA6PF0254


subject: UMLS:C5446872

subject_name: Ponsegromab


subject: UMLS:C5446872


subject: UNII:9ER39U6GCI

subject_name: MIRAVIRSEN SODIUM

object_name: hepatitis C


subject: UNII:9ER39U6GCI

object_name: chronic hepatitis C virus infection


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Advanced renal cell carcinoma


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: CHEBI:63599

subject_name: Fludarabine


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous

object_name: secondary immune deficiency


subject: MESH:C558471

subject_name: Hizentra

object_name: inborn error of immunity


subject: MESH:C558471


subject: UMLS:C4309055

object_name: sickle cell disease


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: glioblastoma


subject: UNII:R8DG7T2D3A

object_name: Childhood Glioblastoma


subject: UNII:R8DG7T2D3A

object_name: adult glioblastoma


subject: CHEBI:46726

subject_name: magnetite


subject: CHEBI:46726


subject: CHEBI:46726


subject: UNII:LDJ89SS0YG

subject_name: Mosunetuzumab

object_name: Richter syndrome


subject: UMLS:C4329313


subject: PUBCHEM.COMPOUND:435949

subject_name: IV


subject: CHEBI:74327

subject_name: Ile-Val


subject: CHEBI:49040

subject_name: Ezetimibe

object_name: peripheral vascular disease


subject: CHEBI:49040

object_name: peripheral arterial disease


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:9150


subject: UMLS:C2353772

object_name: diabetes mellitus


subject: UMLS:C2353772

object_name: gastroparesis


subject: UMLS:C2353772

object_name: Gastroparesis, CTCAE


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: superficial urinary bladder carcinoma


subject: UMLS:C3641122


subject: UMLS:C2095490

subject_name: corticosteroid injection

object_name: osteoarthritis, knee


subject: CHEBI:31797

subject_name: Gadolinium DTPA


subject: CHEBI:180856

subject_name: Hovenoside G


subject: UMLS:C0721529

subject_name: Magnevist


subject: UMLS:C2919045

subject_name: SH L 451 A


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Refractory Central Nervous System Lymphoma


subject: CHEBI:231614

object_name: primary central nervous system lymphoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: MESH:C513941

subject_name: tongxinluo

object_name: acute myocardial infarction


subject: MESH:C513941

object_name: Acute Myocardial Infarction by ECG Finding


subject: CHEBI:31355

subject_name: Carboplatin

object_name: ALK gene mutation


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:63724


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Critical Illness


subject: PUBCHEM.COMPOUND:78357831

subject_name: micafungin

object_name: invasive aspergillosis


subject: UMLS:C0879264


subject: CHEBI:9927

subject_name: Valsartan

object_name: endogenous depression


subject: CHEBI:9927

object_name: major depressive disorder


subject: CHEBI:80343

subject_name: Mecasermin

object_name: retinopathy of prematurity


subject: UMLS:C4305866


subject: UMLS:C1135137

object_name: Childhood Breast Carcinoma


subject: UMLS:C1135137

object_name: breast carcinoma


subject: UMLS:C1135137

object_name: breast cancer


subject: CHEBI:174615

object_name: T-B+ severe combined immunodeficiency due to gamma chain deficiency


subject: CHEBI:174615

object_name: combined immunodeficiency, X-linked


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: UNII:QMS40680K6


subject: CHEBI:5050

subject_name: Fexofenadine

object_name: Food-Drug Interactions


subject: UMLS:C1881373

subject_name: Synthetic Levothyroxine

object_name: thyroid disease


subject: UMLS:C1881373

object_name: endocrine system disorder


subject: CHEBI:18332

subject_name: Levothyroxine


subject: CHEBI:18332


subject: UMLS:C2936885

subject_name: l-Thyroxine [EPC]

object_name: hypothyroidism


subject: UMLS:C2936885

object_name: Hypothyroidism, CTCAE


subject: UMLS:C2936885


subject: UMLS:C2936885


subject: PUBCHEM.COMPOUND:230076

subject_name: Aureolic acid

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:230076

object_name: germ cell tumor


subject: PUBCHEM.COMPOUND:230076

object_name: thymus neoplasm


subject: PUBCHEM.COMPOUND:230076

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:230076

object_name: Mesothelioma


subject: PUBCHEM.COMPOUND:230076

object_name: mesothelial neoplasm


subject: PUBCHEM.COMPOUND:230076

object_name: malignant mesothelioma


subject: CHEBI:31856

subject_name: Plicamycin


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:31856


subject: CHEBI:4877

subject_name: Ethambutol

object_name: Pott Disease


subject: CHEBI:135117

subject_name: ftivazide


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UMLS:C2609633

subject_name: Divalproex Sodium ER

object_name: generalized anxiety disorder


subject: UMLS:C2609633

object_name: panic disorder


subject: UMLS:C2609633

object_name: panic disorder 1


subject: UMLS:C2609633

object_name: bipolar disorder


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: tuberous sclerosis


subject: PUBCHEM.COMPOUND:70789204

object_name: situs inversus


subject: PUBCHEM.COMPOUND:70789204

object_name: tuberous sclerosis 1


subject: UMLS:C5854656

subject_name: STING Agonist CRD3874

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C5854656

object_name: acute myeloid leukemia


subject: CHEBI:3757

subject_name: Clonidine

object_name: Back Pain, CTCAE 5.0


subject: CHEBI:3757

object_name: Back pain


subject: CHEBI:3757

object_name: Back Pain, CTCAE 3.0


subject: CHEBI:5195

subject_name: furazolidone

object_name: Helicobacter pylori [H. pylori] infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:233453

object_name: Herpes simplex type II


subject: CHEBI:35854

subject_name: Valaciclovir


subject: PUBCHEM.COMPOUND:71853

subject_name: Chitosan

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:71853

object_name: prostate cancer


subject: CHEBI:57704

subject_name: cationic chitosan


subject: CHEBI:57704


subject: CHEBI:16261

subject_name: chitosan


subject: CHEBI:16261


subject: CHEBI:94265

subject_name: Cerubidin

object_name: adult acute myeloid leukemia


subject: CHEBI:64677

subject_name: Cerubidine


subject: CHEBI:41977

subject_name: Daunorubicin


subject: CHEBI:91464


subject: CHEBI:63452

subject_name: Midostaurin


subject: PUBCHEM.COMPOUND:132212657

subject_name: Revumenib


subject: PUBCHEM.COMPOUND:132212657


subject: PUBCHEM.COMPOUND:132212657


subject: PUBCHEM.COMPOUND:169490859

subject_name: Revumenib citrate


subject: PUBCHEM.COMPOUND:169490859


subject: PUBCHEM.COMPOUND:169490859


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: Malignant neoplasm of pancreas resectable


subject: CHEBI:174615

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:28901

subject_name: Busulfan


subject: UMLS:C5908067

subject_name: HER2 Inhibitor IAM1363

object_name: HER2 positive bladder cancer


subject: UMLS:C5908067

object_name: HER2 positive breast carcinoma


subject: UMLS:C5908067

object_name: Her2-receptor negative breast cancer


subject: UMLS:C5908067

object_name: HER2 positive colorectal cancer


subject: UMLS:C5908067

object_name: non-small cell lung carcinoma


subject: UMLS:C5908067

object_name: ERBB2 mutation-related tumors


subject: UMLS:C5908067

object_name: CNS metastases


subject: CHEBI:17066

subject_name: (R)-3-hydroxybutyric acid

object_name: type 2 diabetes mellitus


subject: CHEBI:17066

object_name: Diabetes


subject: CHEBI:17066

object_name: diabetes mellitus


subject: CHEBI:17066

object_name: hyperglycemia


subject: CHEBI:17066

object_name: Hyperglycemia, CTCAE


subject: CHEBI:17066

object_name: Glucose in blood specimen above reference range


subject: CHEBI:17066

object_name: Ketosis


subject: CHEBI:17066

object_name: Ketoacidosis


subject: UMLS:C5418080

subject_name: FD Inhibitor ALXN2050

object_name: kidney failure


subject: RXCUI:284885

subject_name: Tears Naturale Forte

object_name: Posterior blepharitis


subject: RXCUI:284885

object_name: Sicca Syndrome


subject: CHEBI:17234

subject_name: D-glucose

object_name: carpal tunnel syndrome 1


subject: CHEBI:17234

object_name: carpal tunnel syndrome


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: HIV infection


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: Childhood Breast Carcinoma


subject: UNII:B72HH48FLU

object_name: breast carcinoma


subject: UNII:B72HH48FLU

object_name: breast cancer


subject: UNII:B72HH48FLU

object_name: Fatigue, CTCAE 5.0


subject: UNII:B72HH48FLU

object_name: Fatigue


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: lupus nephritis


subject: UMLS:C3272840

subject_name: meningococcal polysaccharide vaccine (MPSV4)

object_name: Invasive meningococcal disease


subject: UMLS:C2960908

subject_name: Meningococcal vaccine component


subject: UMLS:C0935952

subject_name: Oncophage

object_name: melanoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: preretinal fibrosis


subject: CHEBI:41879

object_name: papilledema


subject: CHEBI:41879

object_name: retinal edema


subject: CHEBI:7459

subject_name: Naloxone

object_name: substance-related disorder


subject: GTOPDB:4453

subject_name: thrombin

object_name: Hemorrhage


subject: CHEBI:9574

subject_name: Thrombin


subject: UMLS:C1337342

subject_name: thrombin, bovine


subject: UMLS:C0040018


subject: UMLS:C1871272

subject_name: TachoSil


subject: UMLS:C2351971

object_name: liver failure